Company Search:
Advanced Search
Sponsored Links
Eyegene Inc Company Snapshot
Eyegene Inc operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Eyegene Inc with three other companies in this sector in KOREA (SOUTH) : Anterogen Co Ltd (2019 sales of 4.15 billion Korean Won [US$3.67 million] of which 78% was Remodulins), Cube&Company Co Ltd (7.38 billion Korean Won [US$6.54 million] of which 98% was Synthesis), and Oscotec Incorporation (4.37 billion Korean Won [US$3.87 million] of which 67% was Medical Segment).

Sales Analysis. Eyegene Inc reported sales of 4.25 billion Korean Won (US$3.76 million) for the year ending December of 2019. This represents an increase of 108.6% versus 2018, when the company's sales were 2.04 billion Korean Won . This was the fourth straight year of sales growth at Eyegene Inc.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Eyegene Inc
  Stock Performance Chart for Eyegene Inc
  Stock Data: Recent Stock Performance:
  Current Price (10/23/2020): 10,750
(Figures in Korean Won )
1 Week -8.5%   13 Weeks -11.9%  
4 Weeks -10.4%   52 Weeks -23.5%  
Eyegene Inc Key Data:
  Ticker: 185490 Country: Korea (South)
  Exchanges: SEO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 4,245,379,708
(Year Ending Jan 2020).
Employees: 57
  Currency: Korean Won Market Cap: 123,501,966,250
  Fiscal Yr Ends: December Shares Outstanding: 11,488,555
  Share Type: Common Closely Held Shares: 1,602,170
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.